PATHOGENETIC ASPECTS OF PREECLAMPSIA
- Authors: Boris D.A.1, Kan N.E.1, Tyutyunnik V.L.1, Khovkhaeva P.A.1
-
Affiliations:
- Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
- Issue: No 12 (2015)
- Pages: 11-15
- Section: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/247512
- ID: 247512
Cite item
Abstract
Full Text
About the authors
Daiana A. Boris
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: dayana_boris@mail.ru
the resident Moscow 117997, Ac. Oparina str. 4, Russia
Natalia E. Kan
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: kan-med@mail.ru
PhD, MD, the head of the obstetric observation department Moscow 117997, Ac. Oparina str. 4, Russia
Victor L. Tyutyunnik
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: tioutiounnik@mail.ru
PhD, MD, the head of the obstetric physiological department Moscow 117997, Ac. Oparina str. 4, Russia
Petimat A. Khovkhaeva
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: p_hovhaeva@oparina4.ru
the postgraduate student Moscow 117997, Ac. Oparina str. 4, Russia
References
- Sibai B., Dekker G., Kupferminc M. Pre-eclampsia. Lancet. 2005; 365(9461): 785-99.
- Genest D.S., Falcao S., Gutkowska J., Lavoie J.L. Impact of exercise training on preeclampsia: potential preventive mechanisms. Hypertension. 2012; 60(5): 1104-9.
- Mayeur S., Lancel S., Theys N., Lukaszewski M.A., Duban-Deweer S., Bastide B. et al. Maternal calorie restriction modulates placental mito chondrial biogenesis and bioenergetic efficiency: putative involvement in fetoplacental growth defects in rats. Am. J. Physiol. Endocrinol. Metab. 2013; 304(1): Е14-22.
- Poston L., Igosheva N., Mistry H.D., Seed P.T., Shennan A.H., Rana S. et al. Role of oxidative stress and antioxidant supplementation in pregnancy disorders. Am. J. Clin. Nutr. 2011; 94(6, Suppl.): 1980S-5S.
- Burton G.J., Jauniaux E. Oxidative stress. Best Pract. Res. Clin. Obstet. Gynaecol. 2011; 25(3): 287-99.
- Haram K., Svendsen E., Abildgaard U. The HELLP syndrome: clinical issues and management. A review. BMC Pregnancy Childbirth. 2009; 9: 8.
- Савельева Г.М., Шалина Р.И., Курцер М.А., Штабницкий А.М., Куртенок Н.В., Коновалова О.В. Эклампсия в современном акушерстве. Aкушерство и гинекология. 2010; 6: 4-9.
- Khong Y., Brosens I. Defective deep placentation. Best Pract. Res. Clin. Obstet. Gynaecol. 2010; 25(3): 301-11.
- NICE Clinical guideline CG107: Hypertension in Pregnancy: the management of hypertensive disorders during pregnancy. Surveillance proposal GE document, 2015. 71 p. Available at: https://www.nice.org.uk/guidance/cg107/ resources/cg107-hypertension-in-pregnancy-surveillance-review-decision-march-20153
- Redman C.W., Sargent I.L. Placental stress and pre-eclampsia: a revised view. Placenta. 2009; 30(Suppl.A): S38-42.
- Ходжаева З.С., Шмаков Р.Г., Коган Е.А., Щеголев А.И., Клименченко Н.И., Акатьева А.С., Вавина О.В., Воднева Д.Н., Романова В.В., Сухих Г.Т. Клинико-анамнестические особенности, плацента и плацентарная площадка при ранней и поздней преэклампсии. Aкушерство и гинекология. 2015; 4: 25-31.
- Duley L. The global impact of pre-eclampsia and eclampsia. Semin. Perinatol. 2009; 33(3): 130-7.
- Savaj S., Vaziri N. An overview of recent advances in pathogenesis and diagnosis of preeclampsia. Iran. J. Kidney Dis. 2012; 6(5): 334-8.
- Bell M.J. Historical overview of preeclampsia-eclampsia. J. Obstet. Gynecol. Neonatal Nurs. 2010; 39(5): 510-8.
- Huppertz B. Placental origins of preeclampsia: challenging the current hypothesis. Hypertension. 2008; 51(4): 970-5.
- Patni S., Wynen L.P., Seager A.L., Morgan G., White J.O., Thornton C.A. Expression and activity of Toll-like receptors 1-9 in the human term placenta and changes associated with labor at terme. Biol. Reprod. 2009; 80(2): 243-8.
- Roberts J.M., Hubel C. The two stage model of preeclampsia: variations on the them. Placenta. 2009; 30(Suppl.A): S32-7.
- Chandra A., Surti N., Kesavan S., Agarwal A. Significance of oxidative stress in human reproduction. Arch. Med. Sci. 2009; 5(1A): S28-42.
- Fournier T., Thérond P., Handschuh K., Tsatsaris V., Evain-Brion D. PPARgamma and early human placental development. Curr. Med. Chem. 2008; 15(28): 3011-24.
- Shah D.M. Preeclampsia: new insights. Curr. Opin. Nephrol. Hypertens. 2007; 16(3): 213-20.
- Burton G.J., Woods A.W., Jauniaux E., Kingdom J.C. Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta. 2009; 30(6): 473-82.
- Geusens N., Verlohren S., Luyten C., Taube M., Hering L., Vercruysse L. et al. Endovascular trophoblast invasion, spiral artery remodelling and uteroplacental haemodynamics in a transgenic rat model of pre-eclampsia. Placenta. 2008; 29(7): 614-23.
- Espinoza J., Romero R., Mee Kim Y., Kusanovic J.P., Hassan S., Erez O. et al. Normal and abnormal transformation of the spiral arteries during pregnancy. J. Perinat. Med. 2006; 34(6): 447-58.
- Collins S.L., Stevenson G.N., Noble J.A., Impey L. Developmental changes in spiral artery blood flow in the human placenta observed with colour Doppler ultrasonography. Placenta. 2012; 33(10): 782-7.
- Soto E., Romero R., Kusanovic J.P., Ogge G., Hussein Y., Yeo L. et al. Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion. J. Matern. Fetal Neonatal Med. 2012; 25(5): 498-507.
- Lunghi L., Ferretti M.E., Medici S., Biondi C., Vesce F. Control of human trophoblast function. Reprod. Biol. Endocrinol. 2007; 5: 6.
- Huppertz B., Kadyrov M., Kingdom J.C. Apoptosis and its role in the trophoblast. Am. J. Obstet. Gynecol. 2006; 195(1): 29-39.
- Hiden U., Bilban M., Knofler M., Desoye G. Kisspeptins and the placenta: regulation of trophoblast invasion. Rev. Endocr. Metab. Disord. 2007; 8(1): 31-9.
- Young B.C., Levine R.J., Karumanchi S.A. Pathogenesis of preeclampsia. Annu. Rev. Pathol. 2010; 5: 173-92.
- Beauséjour A., Bibeau K., Lavoie J.C., St-Louis J., Brochu M. Placental oxidative stress in a rat model of preeclampsia. Placenta. 2007; 28(1): 52-8.
- Li D., Wen X., Ghali L., Al-Shalabi F.M., Docherty S.M., Purkis P., Iles R.K. hCGß expression by cervical squamous carcinoma - in vivo histological association with tumor invasion and apoptosis. Histopathology. 2008; 53(2): 147-55.
- Lee J., Romero R., Xu Y., Miranda J., Yoo W., Chaemsaithong P. et al. Detection of anti-HLA antibodies in maternal blood in the second trimester to identify patients at risk of antibody-mediated maternal anti-fetal rejection and spontaneous preterm delivery. Am. J. Reprod. Immunol. 2013; 70(2): 162-75.
- Redman C.W., Sargent I.L. Immunology of pre-eclampsia. Am. J. Reprod. Immunol. 2010; 63(6): 534-43.
- Makrigiannakis A., Karamouti M., Drakakis P., Loutradis D., Antsaklis A. Fetomaternal immunotolerance. Am. J. Reprod. Immunol. 2008; 60(6): 482-96.
- Heyl W., Heintz B., Reister F., Harwig S., Witte K., Lemmer B., Rath W. Increased soluble VCAM-1 serum levels in preeclampsia are not correlated to urinary excretion or circadian blood pressure rhythm. J. Perinat. Med. 2005; 33(2): 144-8.
- Smith G. First-trimester determination of complications of late pregnancy. JAMA. 2010; 303(6): 561-2.
- Mehendale R., Hibbard J., Fazleabas A., Leach R. Placental angiogenesis markers sFlt-1 and PlGF: response to cigarette smoke. Am. J. Obstet. Gynecol. 2007; 197(4): 363. e1-5.
- Shibata E., Rajakumar A., Powers R.W., Larkin R.W., Gilmour C., Bodnar L.M. et al. Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor. J. Clin. Endocrinol. Metab. 2005; 90(8): 4895-903.
- Mutter W.P., Karumanchi S.A. Molecular mechanisms of preeclampsia. Microvasc. Res. 2008; 75(1): 1-8.
- Wu F.T., Stefanini M.O., Mac Gabhann F., Kontos C.D., Annex B.H., Popel A.S. A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use. J. Cell. Mol. Med. 2010; 14(3): 528-52.
- Myatt L. Reactive oxygen and nitrogen species and functional adaptation of the placenta. Placenta. 2010; 31(Suppl.): 66-9.
- Crimi M., Rigolio R. The mitochondrial genome, a growing interest inside an organelle. Int. J. Nanomed. 2008; 3(1): 51-7.
- Wallace D.C. Mitochondrial DNA mutations in disease and aging. Environ. Mol. Mutagen. 2010; 51(5): 440-50.
- Heazell A.E., Lacey H.A., Jones C.J., Huppertz B., Baker PN., Crocker I.P Effects of oxygen on cell turnover and expression of regulators of apoptosis in human placental trophoblast. Placenta. 2008; 29(2): 175-86.
- Chen Q., Stone P., Ching L.M., Chamley L. A role for interleukin-6 in spreading endothelial cell activation after phagocytosis of necrotic trophoblastic material: implications for the pathogenesis of pre-eclampsia. J. Pathol. 2009; 217(1): 122-30.
- Jauniaux E., Hempstock J., Greenwold N., Burton G.J. Trophoblastic oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal early pregnancies. Am. J. Pathol. 2003; 162(1): 115-25.
- Panda B., Panda A., Ueda I., Abrahams V.M., Norwitz E.R., Stanic A.K. et al. Dendritic cells in the circulation of women with preeclampsia demonstrate a pro-inflammatory bias secondary to dysregulation of TLR receptors. J. Reprod Immunol. 2012; 94(2): 210-5.
- Burton G.J., Jones C.J. Syncytial knots, sprouts, apoptosis, and trophoblast deportation from the human placenta. Taiwan J. Obstet. Gynecol. 2009; 48(1): 28-37.